CD19 and B-cell chronic lymphocytic leukemia: Paralleling this seminal study, Dr. Carl June’s group at the University of Pennsylvania demonstrated specific and effective on-target killing of CD19+ malignant B cells in patients with advanced chronic lymphocytic leukemia (CLL) using CD19-directed CAR-T cells.